// App-Quantinova.ai

M5277 2016 AHA : New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials

Researchers

Presenter

  • Sana M Al-Khatib

Principal Investigators

  • Emily P Zeitler

  • Alfred Hallstrom

  • Riccardo Cappato

  • Alan H Kadish

  • Peter J. Kudenchuk

  • Daniel B. Mark

  • Lurdes Y.T. Inoue

  • Gillian D. Sanders

  • JooYoon Han

  • Gust H Bardy

  • J. Thomas Bigger

  • Alfred E. Buxton

  • Arthur J Moss

  • Kerry L. Lee

  • Richard Steinman

  • Paul Dorian

Medical Centers

  • Columbia University, New York, NY

  • Beth Israel Deaconess Hospital, Boston, MA

  • Touro Univ, New York, NY

  • Duke Clinical Research Institute, Durham, NC

  • U Toronto, Toronto, ON, Canada

  • Columbia Univ, Durham, NC

  • University of Washington, Seattle, WA

  • IRCCS Policlinico S. Donato, Milan, Italy

  • University of Rochester, Rochester, NY

Locations

  • United States

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Advanced heart failure

  • Myocardial infarction

  • Cardiac arrest

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved